Business Context and Reporting Period
This Form 8-K Current Report was filed by Fluidigm Corporation on August 2, 2018. The filing discloses the entry into a material definitive agreement regarding a new credit facility. Note: The request metadata references "Standard BioTools Inc.," but the filing text explicitly identifies the registrant as Fluidigm Corporation.
Key Financial Metrics and Debt
- Debt Facility: Secured revolving credit facility with Silicon Valley Bank.
- Maximum Amount: Up to $15.0 million principal outstanding at any time.
- Borrowing Base Limit: Loans cannot exceed 85% of eligible receivables and 50% of eligible inventory (subject to a cap on inventory).
- Interest Rates: Prime rate plus 0.50% or a fixed rate of 5.50% (at Company's option).
- Maturity Date: August 2, 2020.
- Collateral: Security interest on substantially all assets, excluding intellectual property (though proceeds from IP are included).
- Prepayment Fees: 2.00% of Maximum Amount if prepaid before August 2, 2019; 1.00% if prepaid between August 2, 2019, and maturity.
The filing text does not provide current revenue, profit, cash flow, or margin figures, as this is a transactional report rather than a periodic financial statement.
Material Changes and Covenants
The primary material change is the establishment of the new debt obligation. The Loan Agreement includes customary affirmative and negative covenants that restrict the Company's ability to:
- Dispose of assets or undergo a change in control.
- Merge, consolidate, or make acquisitions.
- Incur additional debt or liens.
- Pay dividends, repurchase stock, or make investments.
Events of default include payment defaults, covenant breaches, material adverse changes, bankruptcy, and cross-defaults. Upon default, interest rates may increase by 5.0% above the applicable rate.
Outlook and Management Commentary
Management intends to use the proceeds from the loan facility for working capital and general corporate purposes. The filing does not contain forward-looking guidance on revenue or earnings, nor does it detail specific risks beyond those inherent in the loan covenants and default provisions.
Investor Verification Checklist
- Verify the current levels of eligible receivables and inventory to determine the actual available borrowing capacity under the 85%/50% limits.
- Review the specific cap on eligible inventory mentioned in the agreement to assess potential borrowing constraints.
- Monitor compliance with negative covenants, particularly regarding future acquisitions, debt incurrence, or dividend payments.
- Confirm the Company's liquidity position to ensure it can meet monthly interest payments and the principal balance due at maturity in 2020.
- Check for any subsequent filings regarding prepayment or covenant waivers.